Document Detail


Pomegranate Use to Attenuate Bone Loss in Major Musculoskeletal Diseases: An Evidence-Based Review.
MedLine Citation:
PMID:  24200293     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This review explores the effects of pomegranate on the pathogenesis of bone loss in osteoporosis, osteoarthritis and rheumatoid arthritis. A systematic review of the literature was conducted to identify the relevant studies on pomegranate and osteoporosis/osteoarthritis/rheumatoid arthritis. A comprehensive search was conducted in Medline and CINAHL for relevant studies published between the years 1946 to 2012. The main inclusion criteria were research articles published in English, studies had to report the association or effect of pomegranate and these bone and joint diseases: osteoporosis, osteoarthritis or rheumatoid arthritis. The literature search identified 35 potentially relevant articles, whereby 8 met the inclusion criteria. Two animal studies, two combinations of animal and in vitro studies, three in vitro studies and one human study were included in this review. All the studies reported positive effects of pomegranate extract or juice on osteoporosis, osteoarthritis and rheumatoid arthritis. This evidence-based review highlighted the potential of pomegranate extract being used for treating bone loss in osteoporosis, osteoarthritis and rheumatoid arthritis. Further studies are required to identify the active ingredients and molecular mechanisms before controlled human observational studies are conducted to provide stronger evidence.
Authors:
Ahmad Nazrun Shuid; Isa Naina Mohamed
Related Documents :
18551353 - Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and l...
2218753 - Sarcoidosis with nasal obstruction and deformity. a case report.
11144653 - Inflammatory pseudotumor of the bladder in neonates.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-08
Journal Detail:
Title:  Current drug targets     Volume:  -     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-11-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pharmacology, Faculty of Medicine, National University of Malaysia (UKM), Kuala Lumpur Campus, Raja Muda Abdul Aziz Road 50300, Kuala Lumpur, Malaysia. anazrun@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exploiting APC Function as a Novel Cancer Therapy.
Next Document:  Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture.